Rosuvastatin Calcium Tablet, Film Coated
Product Images NDC 68071-3722

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Rosuvastatin Calcium (NDC 68071-3722). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 3722 9)

Label for Rosuvastatin 10 mg film-coated tablets by NuCare Pharmaceuticals, Inc. The package contains 90 tablets. The label includes dosage instructions, manufacturer information, and safety warnings. It displays the NDC 68071-3722-9 and indicates the product is Rx only. Storage instructions specify controlled temperature between 68-77°F.*

FDA Label Image

Figure 1. Time To First Occurrence Of Major Cardiovascular Events In Jupiter (Rosuvastatin Fig1)

A cumulative incidence graph comparing Rosuvastatin Calcium (Rosuva) and placebo over approximately 5 years. The y-axis shows cumulative incidence percentage, and the x-axis represents years. The graph includes hazard ratio (HR 0.56 with 95% CI 0.46 to 0.69) and P-value (<0.001). A table below shows numbers at risk for each group over time.*

FDA Label Image

Figure 2. Major Cv Events By Treatment Group In Jupiter (Rosuvastatin Fig2)

A data table comparing the number of cardiovascular events and hazard ratios for Rosuvastatin Calcium 20 mg versus placebo in a clinical study. The table lists endpoints such as primary major cardiovascular events, cardiovascular death, nonfatal stroke, nonfatal myocardial infarction, hospitalized unstable angina, and arterial revascularization, with event numbers, rates, hazard ratios with 95% confidence intervals, and p-values. A forest plot graphically depicts hazard ratios and confidence intervals for each endpoint.*

FDA Label Image

Figure 3. (Rosuvastatin Fig3)

A box plot chart showing the percent change from baseline in LDL-C levels at different doses (10, 20, 40, 80 mg) for four statin drugs: Rosuvastatin, Atorvastatin, Simvastatin, and Pravastatin. The y-axis represents percent change, ranging from 0 to -75%. The chart compares LDL-C reduction efficacy across these statins and doses.*

FDA Label Image

Chemical Structure (Rosuvastatin Str)

Chemical structure of Rosuvastatin Calcium, showing its molecular framework including fluorophenyl, sulfonyl methyl, hydroxyl, and carboxylate groups, along with the calcium ion (Ca2+) complexation.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.